Brooks Laboratories (BOM:533543) Construction In Progress: ₹11.9 Mil (As of Mar. 2026)


BOM:533543 Brooks Laboratories Ltd BOM:533543
67 GF Score
Price ₹71.26
GF Value ₹117.95
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Brooks Laboratories Construction In Progress?

Brooks Laboratories BOM:533543 +3.26% 67 Construction In Progress is ₹11.9 Mil as of Mar. 2026. GuruFocus rates BOM:533543 with a GF Score™ of 67/100 and a GF Value™ of ₹117.95 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Brooks Laboratories's quarterly construction in progress declined from Sep. 2025 (₹9.2 Mil) to Dec. 2025 (₹0.0 Mil) but then increased from Dec. 2025 (₹0.0 Mil) to Mar. 2026 (₹11.9 Mil).

Brooks Laboratories's annual construction in progress increased from Mar. 2024 (₹0.0 Mil) to Mar. 2025 (₹2.5 Mil) and increased from Mar. 2025 (₹2.5 Mil) to Mar. 2026 (₹11.9 Mil).

Brooks Laboratories Construction In Progress Historical Data

* Premium members only.

The historical data trend for Brooks Laboratories's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brooks Laboratories Construction In Progress Chart

Brooks Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 195.04 0.00 0.00 2.53 11.91

Brooks Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.53 0.00 9.24 0.00 11.91
BOM:533543
67GF Score
Brooks Laboratories Ltd BOM:533543
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Brooks Laboratories Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₹11.9 Mil mean?
Brooks Laboratories (BOM:533543) has a Construction In Progress of ₹11.9 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Brooks Laboratories and its competitors.
Is Brooks Laboratories' Construction In Progress too high?
Brooks Laboratories' current Construction In Progress is ₹11.9 Mil. Overall, Brooks Laboratories has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Brooks Laboratories' Construction In Progress compare to ZTS and UTHR?
Brooks Laboratories' Construction In Progress of ₹11.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Brooks Laboratories and its competitors. Brooks Laboratories's current Construction In Progress is ₹11.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brooks Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Brooks Laboratories (BOM:533543) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹117.95, compared to a current price of ₹71.26 — trading 39.6% below its estimated fair value. The current Construction In Progress is ₹11.9 Mil. Brooks Laboratories' overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Brooks Laboratories (BOM:533543), the current Construction In Progress is ₹11.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Brooks Laboratories (BOM:533543) Overvalued in 2026?

Based on GuruFocus' analysis, Brooks Laboratories stock appears to be undervalued. The current stock price of ₹71.26 is trading 39.6% below its estimated GF Value™ of ₹117.95. GuruFocus considers Brooks Laboratories to be Significantly Undervalued.

Key valuation signals for BOM:533543:

  • Construction In Progress: ₹11.9 Mil
  • GF Value™: ₹117.95 vs. price of ₹71.26 (39.6% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the BOM:533543 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Brooks Laboratories Business Description

Other Exchanges BROOKS:India
Address Near Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is a pharmaceutical manufacturer focused on developing and producing a broad range of generic medicines. Its key segments include injectables, tablets, and dry syrups, with product lines covering antibiotics such as beta-lactams and cephalosporins as well as general critical care injectables. The company operates manufacturing facilities compliant with international quality standards located in India, serving both domestic and international markets. Revenue is generated through contract manufacturing and sales of pharmaceutical formulations distributed broadly across regulated and semi-regulated international markets. The company has obtained regulatory certifications from multiple countries to comply with international standards for pharmaceutical manufacturing.
67GF Score

Get the complete analysis for BOM:533543

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹71.26
Price
₹117.95
GF Value